Screening for Chronic Obstructive Pulmonary Disease in Smoking Cessation ‎Clinic in France

Authors

  • Dewitte Jean-Dominique Tobaccology Center, University Hospital Brest, France
  • Garlantézec Ronan Public Health, University Hospital, Rennes, France
  • Heno Gilles Nurse, Tabacology Center, Public Hospital, Vannes, France
  • Le Bretonnic Maryline Nurse, Tabacology Center, Public Hospital, Vannes, France
  • Lienau Christine Nurse, Tabacology Center, Public Hospital, Vannes, France
  • Perriot Jean Public Health, Conseil General du Puy de Dome, Clermont-Ferrand, France
  • Pougnet Laurence Medical Laboratory, Military Hospital Clermont-Tonnerre, Brest, France
  • Pougnet Richard Tobaccology Center, University Hospital Brest, France
  • Zarrin Alavi Pulmonology INSERM CIC, University Hospital, Brest, France
Abstract:

Background: The purpose of this study was to detect chronic obstructive pulmonary disease (COPD) among smokers seeking treatment for the first time in a smoking cessation clinic and to assess the predictors of positive screening. Methods: This study was based on a multicenter survey with questionnaires (Richmond, Fagerstrom, clinical signs) and spirometry miniaturized. Data were analyzed with SAS® by Pearson chi-square test, the test of analysis of variance, Spearman correlation coefficient, and multivariate logistic regression step down. Findings: 1918 patients were assessed for eligibility and only 1737 were included. The report forced expiratory volume in 1 second (FEV1/FEV6) was < 0.8 for 33.2% of smokers and < 0.7 for 7.5% of them. People with likely COPD had more dyspnea (P < 0.010) and chronic bronchitis (CB) (P < 0.010). In multivariate analysis, CB, duration of smoking history since longer than 30 years, and dyspnea significantly increased the risk of being detected as COPD. The odds ratios of the above factors were 2.9, 4.1, and 4.5, respectively. Conclusion: 7.5% of smokers were likely COPD. Patient’s risk factors, such as the presence of CB, smoking addiction for longer than 30 years, or dyspnea, were predictive of a positive screening for COPD.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Screening for Chronic Obstructive Pulmonary Disease in Smoking Cessation Clinic in France

BACKGROUND The purpose of this study was to detect chronic obstructive pulmonary disease (COPD) among smokers seeking treatment for the first time in a smoking cessation clinic and to assess the predictors of positive screening. METHODS This study was based on a multicenter survey with questionnaires (Richmond, Fagerstrom, clinical signs) and spirometry miniaturized. Data were analyzed with S...

full text

Smoking cessation for chronic obstructive pulmonary disease.

BACKGROUND Smoking cessation is the most important treatment for smokers with chronic obstructive pulmonary disease (COPD), but little is known about the effectiveness of different smoking cessation interventions for this particular group of patients. OBJECTIVES To determine the effectiveness of smoking cessation interventions in people with COPD. SEARCH STRATEGY Electronic searches were un...

full text

Smoking cessation and chronic obstructive pulmonary disease

Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pISSN 1226-3303 eISSN 2005-664...

full text

[Smoking cessation in patients with chronic obstructive pulmonary disease].

BACKGROUND Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more than 80% of cases. Our aim was to investigate the effect of sustained-release bupropion (amfebutamone) (SR) in promoting abstinence from smoking in patients with COPD. METHODS In a double-blind, randomised, placebo-controlled trial 404 individuals with mild or moderate COPD who smoked 15 or more...

full text

Statins and Pulmonary Hypertension in Chronic Obstructive Lung Disease

Chronic obstructive lung disease (COPD) is a chronic multisystem disease with a considerable burden. One of its most common complications is pulmonary artery hypertension (PAH). It has been demonstrated that the development of PAH is correlated with decreased quality of life and survival. Different medications have been proposed for the treatment of PAH, among which one can name statins. Howeve...

full text

Aspergillus colonization in patients with chronic obstructive pulmonary disease

Background and Purpose: Chronic obstructive pulmonary disease (COPD) has been recognized as a risk factor for invasive aspergillosis. Airway colonization by Aspergillus species is a common feature of chronic pulmonary diseases. Nowadays, the incidence of COPD has increased in critically ill patients. The aim of the present study was to isolate and identify Aspergillus colonies in the respirator...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 8  issue 1

pages  1- 8

publication date 2015-12-20

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023